AS
MRNA icon

Altshuler Shaham’s Moderna MRNA Stock Holding History

Altshuler Shaham’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Hold
15,100
– – 0.01% 131
2026
Q1 		$767K Sell
15,100
-7,900
-34% -$369K 0.01% 141
2025
Q4 		$678K Buy
23,000
+7,000
+44% +$190K 0.01% 135
2025
Q3 		$413K Sell
16,000
-10,800
-40% -$301K 0.01% 129
2025
Q2 		$739K Buy
26,800
+8,000
+43% +$211K 0.02% 88
2025
Q1 		$533K Hold
18,800
– – 0.01% 81
2024
Q4 		$782K Buy
18,800
+12,200
+185% +$583K 0.03% 62
2024
Q3 		$441K Buy
6,600
+3,300
+100% +$303K 0.03% 76
2024
Q2 		$392K Hold
3,300
– – 0.01% 77
2024
Q1 		$352K Buy
+3,300
New +$333K 0.01% 71
2023
Q1 		– Sell
-148
Closed -$26.6K – 439
2022
Q4 		$26.6K Sell
148
-758
-84% -$124K ﹤0.01% 327
2022
Q3 		$107K Sell
906
-105
-10% -$15.9K ﹤0.01% 160
2022
Q2 		$144K Buy
+1,011
New +$145K ﹤0.01% 141
2021
Q4 		– Sell
-19
Closed -$7K – 610
2021
Q3 		$7K Sell
19
-1,284
-99% -$474K ﹤0.01% 492
2021
Q2 		$306K Sell
1,303
-1,969
-60% -$352K ﹤0.01% 236
2021
Q1 		$428K Buy
+3,272
New +$474K ﹤0.01% 135

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Altshuler Shaham's MRNA Position: Q2 2026 in Review

Altshuler Shaham held its Moderna (MRNA) position steady in Q2 2026 at 15,100 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #131.

Altshuler Shaham first reported a position in MRNA in Q1 2021 and has held it in 16 quarters since. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Altshuler Shaham held 15,100 shares of Moderna worth $1.06M as of Q2 2026.
  • Altshuler Shaham left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.01% of Altshuler Shaham's portfolio in Q2 2026, its #131 holding.
  • Altshuler Shaham first reported a position in Moderna in Q1 2021 and has held it in 16 quarters since.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Altshuler Shaham's 13F filing for Q2 2026, filed 12 Aug 2026.